• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性血管性水肿:巴西患者的生活质量。

Hereditary angioedema: quality of life in Brazilian patients.

机构信息

Faculdade de Medicina da Universidade de São Paul, Department of Dermatology, São Paulo/SP, Brazil.

出版信息

Clinics (Sao Paulo). 2013 Jan;68(1):81-3. doi: 10.6061/clinics/2013(01)oa13.

DOI:10.6061/clinics/2013(01)oa13
PMID:23420162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3552471/
Abstract

OBJECTIVE

Hereditary angioedema is a serious medical condition caused by a rare autosomal dominant genetic disorder and it is associated with deficient production or dysfunction of the C1 esterase inhibitor. In most cases, affected patients experience unexpected and recurrent crises of subcutaneous, gastrointestinal and laryngeal edema. The unpredictability, intensity and other factors associated with the disease impact the quality of life of hereditary angioedema patients. We evaluated the quality of life in Brazilian hereditary angioedema patients.

METHODS

Patients older than 15 years with any severity of hereditary angioedema and laboratory confirmation of C1 inhibitor deficiency were included. Two questionnaires were used: a clinical questionnaire and the SF-36 (a generic questionnaire). This protocol was approved by the Ethics Committee of Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo.

RESULTS

The SF-36 showed that 90.4% (mean) of all the patients had a score below 70 and 9.6% had scores equal to or higher than 70. The scores of the eight dimensions ranged from 51.03 to 75.95; vitality and social aspects were more affected than other arenas. The internal consistency of the evaluation was demonstrated by a Cronbach's alpha value above 0.7 in seven of the eight domains.

CONCLUSIONS

In this study, Brazilian patients demonstrated an impaired quality of life, as measured by the SF-36. The most affected domains were those related to vitality and social characteristics. The generic SF-36 questionnaire was relevant to the evaluation of quality of life; however, there is a need for more specific instruments for better evaluation.

摘要

目的

遗传性血管性水肿是一种严重的医学病症,由罕见的常染色体显性遗传疾病引起,与 C1 酯酶抑制剂的产生不足或功能障碍有关。在大多数情况下,受影响的患者会经历意想不到的、反复的皮下、胃肠道和喉头水肿危机。疾病的不可预测性、强度和其他因素会影响遗传性血管性水肿患者的生活质量。我们评估了巴西遗传性血管性水肿患者的生活质量。

方法

纳入年龄大于 15 岁、任何严重程度的遗传性血管性水肿且实验室确认 C1 抑制剂缺乏的患者。使用了两种问卷:临床问卷和 SF-36(一般问卷)。本方案获得了圣保罗大学附属医院临床医院伦理委员会的批准。

结果

SF-36 显示,所有患者中有 90.4%(平均值)的得分低于 70,9.6%的得分等于或高于 70。八个维度的得分范围为 51.03 至 75.95;活力和社会方面比其他领域受影响更大。评估的内部一致性通过八个领域中的七个领域的 Cronbach's alpha 值大于 0.7 来证明。

结论

在这项研究中,巴西患者的生活质量受损,这是通过 SF-36 测量得出的。受影响最大的领域是与活力和社会特征相关的领域。通用的 SF-36 问卷与生活质量评估相关;然而,需要更具体的工具来进行更好的评估。

相似文献

1
Hereditary angioedema: quality of life in Brazilian patients.遗传性血管性水肿:巴西患者的生活质量。
Clinics (Sao Paulo). 2013 Jan;68(1):81-3. doi: 10.6061/clinics/2013(01)oa13.
2
Health-related quality of life and its risk factors in Chinese hereditary angioedema patients.中国遗传性血管性水肿患者的健康相关生活质量及其危险因素。
Orphanet J Rare Dis. 2019 Aug 8;14(1):191. doi: 10.1186/s13023-019-1159-5.
3
Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).SF-36v2 在 C1 抑制剂缺乏症(C1-INH-HAE)所致遗传性血管性水肿中的心理测量学研究。
Orphanet J Rare Dis. 2022 Mar 2;17(1):88. doi: 10.1186/s13023-022-02202-2.
4
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.皮下 C1 抑制剂替代疗法预防遗传性血管性水肿发作的患者的长期健康相关生活质量:来自 COMPACT 开放性延伸研究的结果。
Orphanet J Rare Dis. 2021 Feb 15;16(1):86. doi: 10.1186/s13023-020-01658-4.
5
Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project.遗传性血管性水肿患者生活质量问卷的制定:西班牙多中心研究项目(HAE-QoL)。
Health Qual Life Outcomes. 2012 Jul 20;10:82. doi: 10.1186/1477-7525-10-82.
6
Psychometric Field Study of Hereditary Angioedema Quality of Life Questionnaire for Adults: HAE-QoL.遗传性血管性水肿成人生活质量问卷的心理测量学现场研究:HAE-QoL。
J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):464-473.e4. doi: 10.1016/j.jaip.2015.12.010. Epub 2016 Mar 8.
7
Hereditary angioedema: health-related quality of life in Canadian patients as measured by the SF-36.遗传性血管性水肿:通过SF-36量表评估的加拿大患者的健康相关生活质量。
Allergy Asthma Clin Immunol. 2017 Jan 19;13:4. doi: 10.1186/s13223-016-0176-3. eCollection 2017.
8
A single nucleotide deletion at the C1 inhibitor gene as the cause of hereditary angioedema: insights from a Brazilian family.C1 抑制剂基因的单核苷酸缺失是遗传性血管性水肿的病因:来自巴西家族的研究。
Allergy. 2011 Oct;66(10):1384-90. doi: 10.1111/j.1398-9995.2011.02658.x. Epub 2011 May 30.
9
Health-related quality of life among children with hereditary angioedema.遗传性血管性水肿患儿的健康相关生活质量
Pediatr Allergy Immunol. 2017 Jun;28(4):370-376. doi: 10.1111/pai.12712. Epub 2017 Apr 4.
10
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.用于预防遗传性血管性水肿发作的皮下 C1 抑制剂的健康相关生活质量。
J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1733-1741.e3. doi: 10.1016/j.jaip.2017.12.039. Epub 2018 Jan 31.

引用本文的文献

1
One-year real-life outcomes of lanadelumab therapy in Romanian patients with hereditary angioedema due to C1-inhibitor deficiency.罗马尼亚C1抑制剂缺乏所致遗传性血管性水肿患者接受lanadelumab治疗的1年真实生活结局
Front Allergy. 2025 Aug 21;6:1636425. doi: 10.3389/falgy.2025.1636425. eCollection 2025.
2
Impact of hereditary angioedema attacks on health-related quality of life and work productivity.遗传性血管性水肿发作对健康相关生活质量和工作生产力的影响。
World Allergy Organ J. 2025 Jul 28;18(8):101083. doi: 10.1016/j.waojou.2025.101083. eCollection 2025 Aug.
3
A COSMIN systematic review of instruments for evaluating health-related quality of life in people with Hereditary Angioedema.一项关于评估遗传性血管性水肿患者健康相关生活质量的工具的COSMIN系统评价。
Health Qual Life Outcomes. 2025 Feb 13;23(1):12. doi: 10.1186/s12955-025-02342-6.
4
Epidemiology, economic, and humanistic burden of hereditary angioedema: a systematic review.遗传性血管性水肿的流行病学、经济学和人文负担:系统评价。
Orphanet J Rare Dis. 2024 Jul 8;19(1):256. doi: 10.1186/s13023-024-03265-z.
5
A Cross-Sectional Study of Quality of Life in Patients Enrolled in the Romanian Hereditary Angioedema Registry.一项关于罗马尼亚遗传性血管性水肿登记处登记患者生活质量的横断面研究。
Cureus. 2024 Jan 9;16(1):e51959. doi: 10.7759/cureus.51959. eCollection 2024 Jan.
6
Are pediatricians familiar with hereditary angioedema?儿科医生熟悉遗传性血管性水肿吗?
World Allergy Organ J. 2023 Jun 10;16(6):100783. doi: 10.1016/j.waojou.2023.100783. eCollection 2023 Jun.
7
National survey on clinical and genetic characteristics of patients with hereditary angioedema in Latvia.拉脱维亚遗传性血管性水肿患者临床及遗传特征的全国性调查。
Allergy Asthma Clin Immunol. 2023 Apr 8;19(1):28. doi: 10.1186/s13223-023-00783-6.
8
Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study.依替巴肽在巴西 1 型或 2 型遗传性血管性水肿(HAE)和 C1-INH 水平正常的 HAE 患者中的应用:依替巴肽结局调查登记研究的结果。
An Bras Dermatol. 2022 Jul-Aug;97(4):448-457. doi: 10.1016/j.abd.2021.09.009. Epub 2022 May 30.
9
Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).SF-36v2 在 C1 抑制剂缺乏症(C1-INH-HAE)所致遗传性血管性水肿中的心理测量学研究。
Orphanet J Rare Dis. 2022 Mar 2;17(1):88. doi: 10.1186/s13023-022-02202-2.
10
Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report.遗传性血管性水肿患者疾病负担与生活质量的评估及管理:一份共识报告
Allergy Asthma Clin Immunol. 2021 Apr 19;17(1):40. doi: 10.1186/s13223-021-00537-2.

本文引用的文献

1
Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project.遗传性血管性水肿患者生活质量问卷的制定:西班牙多中心研究项目(HAE-QoL)。
Health Qual Life Outcomes. 2012 Jul 20;10:82. doi: 10.1186/1477-7525-10-82.
2
The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression.遗传性血管性水肿患者的人文负担:对健康相关生活质量、生产力和抑郁的影响。
Allergy Asthma Proc. 2010 Sep-Oct;31(5):407-14. doi: 10.2500/aap.2010.31.3394.
3
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema.2010 遗传性血管性水肿诊断、治疗和管理国际共识算法。
Allergy Asthma Clin Immunol. 2010 Jul 28;6(1):24. doi: 10.1186/1710-1492-6-24.
4
Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits.遗传性血管性水肿的静脉注射C1抑制剂自我给药疗法及其相关的生活质量益处。
Eur J Dermatol. 2009 Mar-Apr;19(2):147-51. doi: 10.1684/ejd.2008.0603.
5
Biological activities of C1 inhibitor.C1抑制剂的生物学活性。
Mol Immunol. 2008 Oct;45(16):4057-63. doi: 10.1016/j.molimm.2008.06.028. Epub 2008 Jul 31.
6
Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema.遗传性血管性水肿:最新技术综述,VII:2007年加拿大匈牙利遗传性血管性水肿诊断、治疗和管理国际共识算法
Ann Allergy Asthma Immunol. 2008 Jan;100(1 Suppl 2):S30-40. doi: 10.1016/s1081-1206(10)60584-4.
7
Critical review of generic and dermatology-specific health-related quality of life instruments.对通用型及皮肤科专用的健康相关生活质量量表的批判性综述。
J Invest Dermatol. 2007 Dec;127(12):2726-39. doi: 10.1038/sj.jid.5701142. Epub 2007 Nov 8.
8
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.遗传性和获得性血管性水肿:问题与进展:第三届C1酯酶抑制剂缺乏症研讨会及后续会议论文集
J Allergy Clin Immunol. 2004 Sep;114(3 Suppl):S51-131. doi: 10.1016/j.jaci.2004.06.047.
9
The extent and nature of disability in different urticarial conditions.不同荨麻疹病症中残疾的程度及性质。
Br J Dermatol. 1999 Apr;140(4):667-71. doi: 10.1046/j.1365-2133.1999.02767.x.
10
Quality of life research in pediatric oncology. Research methods and barriers.儿科肿瘤学中的生活质量研究。研究方法与障碍。
Cancer. 1996 Sep 15;78(6):1333-9. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1333::AID-CNCR24>3.0.CO;2-0.